Get 25% discount on our yearly plans! Subscribe now

Key Metrics
Market Cap
Total Shares Outstanding
Book Value
PE Ratio
PS Ratio
PB Ratio
Forward PE Ratio
ROIC
Return on Aseets
Return on Equity
Dividend
Dividend Yield
Balancesheet Metrics
Total Assets
Total Liability
Assets-to-Libability Ratio
Total Current Assets
Total Current Liability
Current Ratio
Quick Ratio
Debt to Equity Ratio
Income Statement Metrics
Net Income
EPS
EBITA
Gross Profit
Gross Profit Margin
Operating Margin
Net Profit Margin
Price Metrics
5 Days MA
10 Days MA
20 Days MA
50 Days MA
200 Days MA
52 Weeks High
52 Weeks low
All Time High
RSI
MACD
Share Stats
Shares Float
Shares Short
% Short
% Insider
% Institutions
News

Profile

BioNano Genomics Inc. UNIT EX 123123 (BNGOU)

BioNano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system comprises an instrument, chip consumables, reagents, and a suite of data analysis tools. BioNano Genomics, Inc. also provides Bionano prep kits and labeling kits that provide the critical reagents and protocols needed to extract and label high molecular weight, or HMW, DNA for use with the Saphyr system; and data solutions that includes a suite of hardware and software for experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. The company was formerly known as BioNanomatrix, Inc. and changed its name to BioNano Genomics, Inc. in October 2011. The company was founded in 2003 and is headquartered in San Diego, California.

Exchange: NASDAQ

IPO Date:

Sector: Other

Industry: Other

Employees: 65

Address:

&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-
&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;&ebsp;Totals
Totals-